Hopefully works better than his self-driving cars
Neuralink, the brain-computer interface startup founded by tech billionaire Elon Musk, has said the US Food and Drug Administration has given permission for its first human clinical trials.
The clearance is a critical milestone in the development of its brain implant after Neuralink had struggled to obtain official approval for human brain-implant experimentation, despite Musk repeatedly claiming that it was close to begin testing on people for years. Last year in December during the company’s latest show and tell, he said its N1 device could be inserted into humans in just six months.
Now, his promises might just be turning true. «We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!» the biz said on Twitter.
«This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.
